Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 176
- +4 vs. Q2 2022
- Portfolio value
- $6.97B
- −$106.5M (−1.5%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PRCTPROCEPT BioRobotics Corp | COM | 589,262 | $24.4M | 0.4% | −6,118−1.0% | Reduced | History |
| CSTLCastle Biosciences Inc | COM | 941,871 | $24.6M | 0.4% | +812+0.1% | Added | History |
| ATRCAtriCure, Inc. | COM | 642,447 | $25.1M | 0.4% | +551+0.1% | Added | History |
| MGNXMacrogenics Inc | COM | 7,325,514 | $25.3M | 0.4% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 625,461 | $25.5M | 0.4% | −4,978−0.8% | Reduced | History |
| VEEVVeeva Systems Inc | Stock | 157,591 | $26.0M | 0.4% | −11,185−6.6% | Reduced | History |
| KZRKezar Life Sciences, Inc. | COM | 3,031,000 | $26.1M | 0.4% | −4,000−0.1% | Reduced | History |
| BEAMBeam Therapeutics Inc. | COM | 571,721 | $27.2M | 0.4% | −900−0.2% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 653,814 | $27.3M | 0.4% | +73,927+12.7% | Added | History |
| MRSNMersana Therapeutics, Inc. | COM | 4,082,600 | $27.6M | 0.4% | +187,400+4.8% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 265,270 | $27.7M | 0.4% | −817−0.3% | Reduced | History |
| ESPREsperion Therapeutics, Inc. | COM | 4,225,264 | $28.3M | 0.4% | −10,000−0.2% | Reduced | History |
| IQVIQVIA Holdings Inc. | Stock | 160,227 | $29.0M | 0.4% | −8,371−5.0% | Reduced | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 657,188 | $29.1M | 0.4% | −44,880−6.4% | Reduced | History |
| PACBPacific Biosciences of California, Inc. | COM | 5,439,551 | $31.6M | 0.5% | −521,678−8.8% | Reduced | History |
| PFEPfizer Inc | Stock | 767,300 | $33.6M | 0.5% | −68,384−8.2% | Reduced | History |
| IDXXIDEXX Laboratories Inc | COM | 108,822 | $35.5M | 0.5% | −6,951−6.0% | Reduced | History |
| PENPenumbra Inc | COM | 189,774 | $36.0M | 0.5% | −2,814−1.5% | Reduced | History |
| OMCLOmnicell, Inc. | COM | 414,284 | $36.1M | 0.5% | −11,539−2.7% | Reduced | History |
| TMOThermo Fisher Scientific Inc. | Stock | 72,144 | $36.6M | 0.5% | +326+0.5% | Added | History |
| EXASExact Sciences Corp | COM | 1,129,653 | $36.7M | 0.5% | +371,630+49.0% | Added | History |
| HALOHalozyme Therapeutics, Inc. | COM | 930,500 | $36.8M | 0.5% | −40,800−4.2% | Reduced | History |
| OMOutset Medical, Inc. | COM | 2,417,456 | $38.5M | 0.6% | +90,738+3.9% | Added | History |
| GMEDGlobus Medical Inc | Stock | 647,163 | $38.6M | 0.6% | −9,518−1.4% | Reduced | History |
| ACCDAccolade, Inc. | COM | 3,571,870 | $40.8M | 0.6% | −63,016−1.7% | Reduced | History |
| ABMDAbiomed Inc | COM | 166,355 | $40.9M | 0.6% | −3,154−1.9% | Reduced | History |
| CNCCentene Corp | Stock | 528,440 | $41.1M | 0.6% | −17,463−3.2% | Reduced | History |
| EXELExelixis, Inc. | COM | 2,673,500 | $41.9M | 0.6% | −5,000−0.2% | Reduced | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 101,818 | $42.5M | 0.6% | +10,657+11.7% | Added | History |
| CDNACareDx, Inc. | COM | 2,601,446 | $44.3M | 0.6% | +63,922+2.5% | Added | History |
| SILKSilk Road Medical Inc | COM | 1,047,356 | $47.1M | 0.7% | +700.0% | Added | History |
| MDTMedtronic plc | Stock | 615,926 | $49.7M | 0.7% | −29,580−4.6% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,800,000 | $50.6M | 0.7% | +875,000+94.6% | Added | History |
| CRLCharles River Laboratories International, Inc. | COM | 262,993 | $51.8M | 0.7% | +31,924+13.8% | Added | History |
| CICigna Group | Stock | 188,701 | $52.4M | 0.8% | −4,956−2.6% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 285,789 | $52.5M | 0.8% | −6,982−2.4% | Reduced | History |
| AMEDAmedisys Inc | COM | 598,934 | $58.0M | 0.8% | +13,780+2.4% | Added | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 928,305 | $60.7M | 0.9% | +6,300+0.7% | Added | History |
| HUMHumana Inc | Stock | 134,206 | $65.1M | 0.9% | −11,103−7.6% | Reduced | History |
| EVHEvolent Health, Inc. | CL A | 1,869,055 | $67.2M | 1.0% | −149,466−7.4% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,007,444 | $68.8M | 1.0% | −198,978−16.5% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 3,214,704 | $69.2M | 1.0% | −406,858−11.2% | Reduced | History |
| DXCMDexcom Inc | COM | 860,460 | $69.3M | 1.0% | −68,048−7.3% | Reduced | History |
| INSPInspire Medical Systems, Inc. | COM | 401,768 | $71.3M | 1.0% | −5,289−1.3% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 334,838 | $74.6M | 1.1% | −8,144−2.4% | Reduced | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 1,566,015 | $74.9M | 1.1% | +250,142+19.0% | Added | History |
| SWAVShockwave Medical, Inc. | COM | 276,132 | $76.8M | 1.1% | −94,567−25.5% | Reduced | History |
| MOHMolina Healthcare, Inc. | COM | 240,590 | $79.4M | 1.1% | −7,723−3.1% | Reduced | History |
| OPCHOption Care Health, Inc. | COM NEW | 2,629,172 | $82.7M | 1.2% | −258,087−8.9% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 755,898 | $83.6M | 1.2% | −383,557−33.7% | Reduced | History |
| FATEFate Therapeutics Inc | COM | 3,746,086 | $84.0M | 1.2% | +196,000+5.5% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 1,025,715 | $84.8M | 1.2% | +15,088+1.5% | Added | History |
| PODDInsulet Corp | Stock | 373,953 | $85.8M | 1.2% | −12,382−3.2% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 202,492 | $92.0M | 1.3% | −6,008−2.9% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 4,680,162 | $92.3M | 1.3% | +1,296,900+38.3% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 4,204,820 | $94.1M | 1.3% | +172,558+4.3% | Added | History |
| DHRDanaher Corp | Stock | 367,435 | $94.9M | 1.4% | +3,399+0.9% | Added | History |
| SYKStryker Corp | Stock | 476,932 | $96.6M | 1.4% | −702−0.1% | Reduced | History |
| ARVNArvinas, Inc. | COM | 2,190,762 | $97.5M | 1.4% | +66,486+3.1% | Added | History |
| MYOVMyovant Sciences Ltd. | COM | 5,912,639 | $106.2M | 1.5% | −7,000−0.1% | Reduced | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 823,839 | $109.8M | 1.6% | −94,068−10.2% | Reduced | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 4,058,792 | $114.8M | 1.6% | −4,000−0.1% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 2,970,678 | $116.3M | 1.7% | −2,500−0.1% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 3,804,047 | $147.3M | 2.1% | −46,124−1.2% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 296,754 | $149.9M | 2.2% | −5,290−1.8% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,569,851 | $151.9M | 2.2% | −3,956−0.3% | Reduced | History |
| AXNXAxonics, Inc. | COM | 2,193,200 | $154.5M | 2.2% | −120,652−5.2% | Reduced | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 3,329,279 | $154.9M | 2.2% | −20,100−0.6% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 898,092 | $168.3M | 2.4% | −11,256−1.2% | Reduced | History |
| INCYIncyte Corp | COM | 2,744,277 | $182.9M | 2.6% | −29,100−1.0% | Reduced | History |
| MRNAModerna, Inc. | Stock | 1,559,801 | $184.4M | 2.6% | −17,550−1.1% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 956,762 | $191.5M | 2.7% | −101,424−9.6% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 2,855,146 | $303.2M | 4.4% | +10,841+0.4% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 919,346 | $331.9M | 4.8% | −14,457−1.5% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 1,158,126 | $335.3M | 4.8% | −18,010−1.5% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 9,463,400 | $418.6M | 6.0% | −313,128−3.2% | Reduced | History |
Sold out since Q2 2022 (11)
Positions held at the end of Q2 2022 that are gone from this filing.
| Security | Class | Shares in Q2 2022 | Value in Q2 2022 | % of portfolio in Q2 2022 | History |
|---|---|---|---|---|---|
| Radius Health, Inc.750469207 | COM NEW | 8,796,538 | $91.2M | 1.3% | – |
| ONEM1Life Healthcare Inc | COM | 836,190 | $6.56M | 0.1% | History |
| HCATHealth Catalyst, Inc. | COM | 424,611 | $6.15M | 0.1% | History |
| ALKSAlkermes plc. | SHS | 107,200 | $3.19M | <0.1% | History |
| PCRXPacira BioSciences, Inc. | COM | 51,936 | $3.03M | <0.1% | History |
| SNYSanofi | SPONSORED ADR | 42,300 | $2.12M | <0.1% | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 31,000 | $1.85M | <0.1% | History |
| NVCRNovoCure Ltd | ORD SHS | 25,300 | $1.76M | <0.1% | History |
| KURAKura Oncology, Inc. | COM | 63,700 | $1.17M | <0.1% | History |
| ARCTArcturus Therapeutics Holdings Inc. | COM | 39,550 | $623.0K | <0.1% | History |
| SLNSilence Therapeutics plc | ADS | 30,483 | $361.0K | <0.1% | History |